Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.Read More
Global drugmakers rush to boost US presence as tariff threat looms
Related Posts
Add A Comment
